Clinical Trials Logo

Pulmonary Nodule, Multiple clinical trials

View clinical trials related to Pulmonary Nodule, Multiple.

Filter by:

NCT ID: NCT04165603 Recruiting - Clinical trials for Pulmonary Nodule, Solitary

Fluorescence-navigated Thoracoscopy for Detection of Small Pulmonary Nodules

Start date: December 18, 2018
Phase: N/A
Study type: Interventional

Fluorescence-navigated thoracoscopic imaging with indocyanine green (ICG) is a novel technique for detection of small pulmonary nodules other than traditional radiography or intraoperative palpation. As a non-targeted fluorescent contrast agent, ICG accumulates in tumors by the enhanced permeability and retention effect (EPR), making the lesions fluoresce under fluorescent imaging. However, the optimal dosage and injection time of ICG are still under exploration. Hence, we perform this study in humans made up of four groups to determine the optimal time and dose.

NCT ID: NCT04076696 Completed - Clinical trials for Pulmonary Nodule, Solitary

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Start date: August 26, 2020
Phase: N/A
Study type: Interventional

This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.

NCT ID: NCT03992183 Active, not recruiting - Clinical trials for Pulmonary Nodule, Solitary

Utility of CAML as Diagnostic for Early Stage Lung Cancer

Start date: May 21, 2019
Phase:
Study type: Observational

Primary Objective Determine the prevalence of CAMLS in patients with pulmonary nodules. Secondary Objectives Determine the positive and negative predictive value of CAMLS in patients with pulmonary nodules who undergo biopsy. Model combinations of clinical factors with the presence/absence of CAMLS to refine strategies for assessment of patients with pulmonary nodules. Evaluate whether these measures result in enhanced T-cell activity and/or NK cell function and number

NCT ID: NCT03753724 Completed - Lung Cancer Clinical Trials

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study

IDEAL
Start date: August 29, 2018
Phase:
Study type: Observational

This study aims to test the use of novel CT image analysis techniques to enable a better characterisation of small pulmonary nodules. The study will incorporate solid and predominantly solid nodules of 5-15 mm scanned using a variety of scanner types, imaging protocols and patient populations. The investigators hope that the new image processing techniques will improve the accuracy of lung nodule analysis which will in turn reduce the number of unnecessary investigations for benign nodules and may increase the accuracy of the early diagnosis of lung cancer in malignant nodules. This study aims to test this novel analysis software to subsequently allow validation.

NCT ID: NCT03159377 Completed - Clinical trials for Pulmonary Nodule, Multiple

Ultra-Low Dose CT Denoising for Lung Nodule Detection

Start date: July 4, 2017
Phase:
Study type: Observational

We will perform an ultra low-dose CT (ULDCT) in addition to a regular chest CT scan for adult patients undergoing a clinically indicated chest CT. Using a recently developed computationally efficient algorithm for the denoising of ULDCT scans after image reconstruction, we will compare the sensitivity, specificity and accuracy of lesion detection with the ULDCT as compared to the regular CT scan.

NCT ID: NCT03097627 Completed - Clinical trials for Pulmonary Nodule, Solitary

Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

Start date: February 1, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.